Back to Journals » OncoTargets and Therapy » Volume 6

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,647 | Dovepress* | 12,934+ | 3,150 | 16,084 | |
PubMed Central* | 7,713 | 2,097 | 9,810 | ||
Totals | 20,647 | 5,247 | 25,894 | ||
*Since 5 March 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar